Phase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Colorectal Cancer|Pancreatic Cancer|Bladder Cancer|Ovarian Cancer
Interventions: BIOLOGICAL: CDX-1307
Sponsor: Celldex Therapeutics